Mechanistically, METTL16 methylates mRNAs encoding branched-chain amino acid (BCAA) metabolic enzymes BCAT1 and BCAT2 in human AML cells, but not in normal HSPCs. Here, METTL16 is linked to acute myeloid leukemia.